Table 2. Outcomes of patients living in communities with HBC available (HBC+) and not living in such communities (HBC−).

	HBC+ N = 84	HBC− N = 439	P Value∧
Alive and on antiretroviral treatment	67 (80%)	361 (82%)	0.6
Died	14 (17%)	55 (13%)
Lost to follow-up	2 (2%)	17 (4%)
Stopped Treatment	1 (1%)	6 (1%)

Percentages represent percentage of patients within HBC− or HBC+ group.

^∧P value compares Alive and on antiretroviral treatment (favorable outcome) to Died or Lost to follow-up or Stopped treatment (unfavorable outcome).